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Kruziki et al. present a small protein scaffold (Gp2) that enables simple de novo ligand discovery and evolution toward multiple targets. Gp2 uniquely combines robust evolution, small size (45 amino acids), nanomolar affinity, and high thermal stability.
INTRODUCTION
Molecules that bind targets specifically and with high affinity are useful clinically for imaging, therapeutics, and diagnostics as well as scientifically as reagents for biological modulation, detection, and purification. Antibodies have been successfully used for these applications in many cases, but their drawbacks have instigated a search for alternative protein scaffolds from which improved binding molecules can be developed (Banta et al., 2013; Stern et al., 2013) . Biodistribution mechanisms such as extravasation (Schmidt and Wittrup, 2009; Yuan et al., 1995) and tissue penetration (Thurber et al., 2008a (Thurber et al., , 2008b are limited by large size (150 kDa for immunoglobulin G, 50 kDa for antigen-binding fragments, and even 27 kDa for single-chain variable fragments), thereby reducing delivery to numerous locales including many solid tumors. In addition, large size and FcRn-mediated recycling slow plasma clearance (Lobo et al., 2004) . While beneficial for minimally toxic molecular therapeutic applications, slow clearance greatly hinders molecular imaging and systemically toxic therapeutics such as radioimmunotherapy (Wu and Senter, 2005) via high background. Smaller agents yield improved results (Natarajan et al., 2013; Orlova et al., 2009; Zahnd et al., 2010) . Moreover, small size does not preclude therapeutic applications where blocking a protein or protein interaction is required . As scientific reagents, small size aids synthesis and selective conjugation, including protein fusion. Yet significant reduction in scaffold size increases the challenge of balancing evolved intermolecular interaction demands for affinity Engh and Bossemeyer, 2002) or function while retaining beneficial intramolecular interactions for stability and solubility.
Protein scaffolds, frameworks upon which numerous functionalities can be independently engineered, offer a consistent source of binding reagents for the multitude of biomarkers and applications thereof (Banta et al., 2013; Sidhu, 2012; Stern et al., 2013) . A successful protein scaffold should be efficiently evolvable to contain all of the following properties. High affinity (low-nanomolar dissociation constant) and specificity provide potent delivery (Schmidt and Wittrup, 2009; Zahnd et al., 2010) , reduce side effects in clinical applications, and are requisite for precise use in biological study. Stable protein scaffolds provide tolerance to mutations in the search for diverse and improved function (Bloom et al., 2006) , resistance to chemical and thermal degradation in production and synthetic manipulation, in vivo integrity to avoid immunogenicity and off-target effects (Hermeling et al., 2004; Rosenberg, 2006) , and robustness to harsh washing conditions in vitro. Contrary to the multi-domain architecture of many antibodies and fragments, single-domain architecture facilitates production of native ligands as well as incorporation into protein fusions and other multicomponent systems. Cysteine-free structure allows for bacterial production in the reducing Escherichia coli cellular environment, intracellular stability in mammals, and the option of a genetically introduced thiol for site-specific chemical conjugation.
A multitude of alternative protein scaffolds have arisen that possess many of these beneficial properties (Table S1 ). Fibronectins (11 kDa) (Koide et al., 1998; Lipovsek, 2011) , nanobodies (11 kDa) (Revets et al., 2005) , designed ankyrin repeat proteins (20 kDa) (Tamaskovic et al., 2012) , and anticalins (20 kDa) (Gebauer and Skerra, 2012) have been evolved to interact with numerous targets with high affinity while maintaining stability. However, the relatively large size of these scaffolds leaves room for potential improvement in solid tumor penetration and biodistribution through decreased size. Very small size has been achieved in the case of the cystine knottin scaffold (20-50 amino acids) (Moore et al., 2012) and cyclic peptides (17 amino acids) (Heinis et al., 2009) . Knottins often use grafting of known binding motifs, which is only applicable to a subset of targets (Ackerman et al., 2014) , although binders have been evolved from naive libraries (Getz et al., 2011) . Peptides, partially due to limited potential for interfacial area as well as the entropic cost of conformational flexibility (Castel et al., 2011) , often require extensive optimization to yield the affinity and specificity required for many applications. In addition, the multiple disulfide bonds required for stabilization can complicate production and range of application in both cases. Slightly larger scaffolds, such as Fynomers (63 amino acids) , affitin (65 amino acids) , or sso7d (63 amino acids) (Gera et al., 2011) , have moved closer to the small size of knottins and bicyclic peptides without the need for disulfides. Affibodies (58 amino acids) are the smallest heavily investigated disulfide-free scaffold in the literature (Lö fblom et al., 2010) . Their helical paratope has provided high affinity toward many targets; however, they are typically severely destabilized after mutation (midpoint of thermal denaturation [T m ] range, 37
C-65 C; median, 46 C) (Hackel, 2014) . There is still space to develop a scaffold that approaches the small size of knottins and peptides but also possesses the other beneficial properties.
We hypothesized that a thorough exploration of known protein topologies could reveal an effective scaffold that pushed current limits of small size with potential for high affinity and retention of stability. A search of the PDB was performed to identify a small protein with characteristics amenable to use as a protein scaffold, including retention of stability upon mutation, lack of disulfides, and large available binding surface. Gene 2 protein from T7 phage was selected as the scaffold to investigate further, based on the considered characteristics. A library of truncated gene 2 protein (Gp2) mutants was created by diversifying two solventexposed loops in the protein. Using yeast surface display and affinity maturation, target-specific Gp2 molecules with nanomolar or better affinity to three model proteins were isolated. The binding proteins retained the wild-type secondary structure characteristics and remained folded up to an average 72 C. These results verified Gp2 as a promising scaffold for the isolation of strong, specific binders to a wide variety of targets and motivated ligand discovery for the cancer biomarker epidermal growth factor receptor (EGFR). EGFR is a clinical biomarker for imaging and therapy due to its overexpression in multiple cancer types, including head and neck, breast, bladder, prostate, kidney, colorectal, non-small cell lung cancer, and glioma carcinoma (Corcoran and Hanson, 2013; Hynes and MacDonald, 2009) . Improved EGFR targeting could empower molecular imaging for patient stratification (Laurent-Puig et al., 2009; Moroni et al., 2005; Scartozzi et al., 2009 ) and treatment monitoring as well as advanced therapeutics. An EGFR-binding Gp2 was isolated and matured. Binding was verified for membrane-bound EGFR on mammalian cells, and Gp2 was used to detect relative EGFR expression levels across multiple cell lines. The unique combination of small size and efficient evolution of high affinity and stability give Gp2 significant potential for the development of molecular targeting agents.
RESULTS

Scaffold Discovery and Library Construction
The structural information in the PDB was surveyed to locate potential binding scaffolds. Based on the efficacy of diversifying loops at one end of a b sandwich in antibody domains and the type III fibronectin domain, we sought scaffolds with solventexposed loops on a b-sheet-rich framework. As two loops can provide sufficient diversity for high-affinity binding while a single loop is often insufficient (Lipovsek et al., 2007) , we sought protein topologies with two adjacent loops amenable to mutation. All proteins in the PDB were filtered to identify single domains of 40-65 amino acids and at least 30% b-sheet content, although the PDB filter also anomalously returned several proteins as large as 70 amino acids and with only 25% b-sheet content. Resultant proteins were visualized in PyMol. Those with two adjoining loops (regions of at least four amino acids without defined secondary structure) and no disulfide bonds were retained. The potential of the diversified loops to provide sufficient binding interface while maintaining a folded protein was assessed via two metrics: (1) solvent-accessible surface area of the loop amino acids was calculated using serine as the sidechain basis for all diversified sites to avoid wild-type sequence bias; and (2) the average destabilization upon random mutation of the loops was computed using Eris (Yin et al., 2007) . Multiple proteins exhibited favorable properties within several categories ( Figure 1 ). One scaffold that performed well on all criteria, especially differentiated by loop orientation, surface area (709 Å 2 , second highest), and stability (DDG f,mut = 5.6 kcal/mol, third lowest), was selected for focused investigation: T7 phage gene 2 protein (Cá mara et al., 2010) . T7 phage gene 2 protein, an E. coli RNA polymerase inhibitor from T7 phage with 64 amino acids, was the top protein selected by the ranking system (Figure 2) . The coils at the N and C termini (14 and 5 amino acids, respectively) were genetically removed to minimize protein size. In addition, a framework mutation (I17V) was made on the basis of 59% frequency in naturally occurring homologs and computational stabilization (DDG f,I/V = À3.8 kcal/mol via Eris; Yin et al., 2007) . These modifications resulted in the 5.2-kDa, 45-amino-acid Gp2 scaffold.
To evaluate the potential of Gp2 as a protein scaffold for molecular recognition, a combinatorial library of selectively randomized Gp2 sequences was constructed for use in discovery and directed evolution. Two loops, comprising amino acids E7-S12 and V34-E39 (Figure 2 ), were selected as the proposed binding surface, based on their lack of defined secondary structure, continuous solvent-exposed face, and high solvent-exposed surface area (709 Å 2 ). A yeast surface displayed library, containing approximately 4 3 10 8 Gp2 molecules based on the number of yeast transformants, was constructed by randomizing six amino acids from each loop using amino acid frequencies consistent with antibody complementarity-determining regions (CDRs) , and allowing loop length diversity of six, seven, or eight amino acids in each loop (Figure 2 ). Hemagglutinin (HA) and c-MYC epitope tags placed upstream and downstream of the Gp2 gene, respectively, allowed for differentiation through flow cytometry of yeast that lost the plasmid (HA . A quality control check by flow cytometry indicated that 44% of yeast harboring plasmid expressed full-length Gp2. This was supported through sequencing Gp2 genes, resulting in four full-length Gp2 genes, one Gp2 containing stop codon in the diversified loop and five frameshifted genes. Therefore, the actual size of the library was 1.8 3 10 8 unique, full-length Gp2
proteins. Amino acid diversity matched the designed distribution (median absolute deviation, 0.5%; Figure S1 ).
Yeast Surface Display Selection against Model Protein Targets
Lysozyme and immunoglobulin G (IgG) from rabbit and goat were chosen as the first targets for evaluating the binding potential of the Gp2 scaffold. The differing size and surface topologies of lysozyme (14 kDa) and the IgG proteins (150 kDa) test the ability of the scaffold to target diverse proteins (Diamond, 1974; Harris et al., 1998) . The similarity of the two IgG proteins test the ability of Gp2 to create very specific ligands, i.e. binding to goat IgG but not rabbit IgG and vice versa. During each evolutionary round, the Gp2 library underwent two sorts to enrich specific binders (either with target-coated magnetic beads or through fluorescence-activated cell sorting [FACS] ) and one c-MYC + sort to isolate full-length Gp2. Sorted Gp2 sequences were mutated through parallel error-prone PCR reactions targeting the loops or the entire gene and transformed into yeast with loop shuffling driven by homologous (B) PDB ID, amino acid length, % b strand, and % a helix are all from the PDB. Loop residues are identified as residues between secondary structural elements. Loop accessible surface area (ASA) is calculated using GetArea after mutating loop residues to serines within PyMol. DDG f,mut was calculated for random loop mutants using Eris. Fibronectin (1ttg) and Affibody (2b88) are included for comparison. See also Table S1 for commonly used scaffolds.
recombination . After a single maturation cycle, clear binding was evident by flow cytometry for each target campaign (data not shown). Two to four rounds of selection and mutation were carried out for each target to isolate binders with low-nanomolar to picomolar affinity.
Single clones were isolated at the end of rounds where strong binding was detectable by FACS. Target affinity on the surface of yeast was determined by concentration titration (Table 1; Figure 3A ). Affinities measured on the surface of yeast have been previously shown to match affinities measured by surface plasmon resonance and related techniques (Gai and Wittrup, 2007) . The goat IgG-binding population contained one dominant sequence family that had affinities as strong as 200 ± 100 pM after one mutagenic cycle. The rabbit IgG-binding population contained a family of low-nanomolar affinity binders at the end of the third mutagenic cycle, which improved to 2.3 ± 1.4 nM after another round of affinity maturation. A single dominant clone group was isolated for lysozyme binders after the second round of mutagenesis, albeit with weaker binding. Lysozyme-binding clones isolated in subsequent rounds showed point mutations but no significant increase in binding affinity. A sublibrary was created in which amino acid diversity was chosen based on weighted scores of parental binding sequences, computational stability analysis (using FoldX), natural homolog sequences, and potential for complementarity ( Figure S2 ). The strongest library member isolated was GaLys A0.3.3 with an affinity of 0.9 ± 0.7 nM ( Figure 3A) . During selection and maturation, the lysozyme target was always displayed as a complex with streptavidin. Resultantly, GaLys A0.3.3 bound to a streptavidin-lysozyme complex but not streptavidin or lysozyme alone. Nevertheless, this still supports Gp2 as able to generate specific, high-affinity binders to the target presented.
To examine target specificity, the strongest binding ligand from each target campaign was incubated with four proteins at 1 mM. All Gp2 proteins show strong binding to the target protein for which they were selected and matured, while showing fluorescence only slightly above background signal for the three other proteins ( Figure 3B ). Four depletion sorts were performed per round, consisting of two sorts to bare streptavidin-coated beads and two sorts to non-target protein-coated beads. This sorting process enabled only Gp2 binders to the protein of interest to be carried through the affinity maturation process.
Soluble Protein Characterization
To examine whether untethered Gp2 will retain its useful properties, the protein was produced and tested for binding and stability. Wild-type Gp2 could not be produced at detectable levels in a typical production E. coli strain, likely due to the native RNA polymerase inhibition function of the protein (Nechaev and Severinov, 1999) . However, mutated clones were able to be produced, presumably due to mutation of many of the residues on Gp2 normally required to interact with DNA during transcription inhibition (Cá mara et al., 2010) . Protein titer, with no optimization, varied between 0.2 and 2.2 mg/l for different Gp2 mutants. The JE1 E. coli strain has the b-jaw portion of the E. coli RNA polymerase protein deleted (Ederth et al., 2002) , and enabled production of wild-type Gp2 at 0.7 mg/l. All Gp2 molecules were verified by mass spectrometry to within 0.1% of the expected mass.
Structure and stability after mutation are important qualities of a potential protein scaffold. To evaluate secondary structure changes after Gp2 was evolved for new binding function, circular dichroism measurements were taken of the top binder for each target. The ellipticity spectra of the binding Gp2 proteins deviate only slightly from those of wild-type Gp2, suggesting that the secondary structure remains relatively unchanged after multiple mutations in the backbone and entirely new loop regions Loop 1 and Loop 2 indicate amino acid sequences in the diversified loops (E7-S12 and V34-E39). Framework indicates mutations outside of the loops resulting from error-prone PCR during evolution. K D values represent equilibrium dissociation constants for clones displayed on the surface of yeast or as purified soluble protein (±SD for n R 3). T m indicates the midpoint of thermal denaturation as measured by circular dichroism (±SD for n = 2). ND, data not determined.
Figure 2. Solution Structure of Gp2
Diversified amino acids are highlighted in red and underlined in sequence. The N-and C-terminal tails removed to create the Gp2 scaffold are highlighted in blue. An I17V (boldface in sequence) mutation was added based on prevalence in homologous protein sequences. Images created in Macpymol (PDB: 2WNM).
( Figure 4A ). The midpoint of thermal denaturation of each protein was measured by monitoring the loss of secondary structure at 218 nm as temperature increased (Table 1 ; Figure 4B ). Interestingly, the average stability of Gp2 binding mutants increased by 5 C over wild-type Gp2, which had a T m = 67 C ± 1 C. Gp2 mutants raised to 98 C and brought down to room temperature had circular dichroism spectra similar to the initial measurements ( Figure 4A ). GaGIgG 2.2.1 (containing a framework mutation, R44E, to increase production) maintained binding activity ( Figure 4D ) after reverse-phase high-performance liquid chromatography (HPLC) and heating to 98 C, illustrating the chemical and thermal stability of the protein.
The binding affinities of select soluble Gp2 clones, measured by equilibrium competition titration, were 0.4 ± 0.3 nM for Ga GIgG 2.2.1 and 1.0 ± 0.5 nM for GaRIgG 3.2.3 (Table 1 ; Figure 4C ), showing good agreement with the K D s obtained from yeast surface display affinity titration.
EGFR-Targeting Gp2 Domains
The success and ease of ligand discovery for the three model targets from the current Gp2 library motivated the search for a Gp2 ligand that strongly and specifically bound EGFR for use in cancer imaging or treatment. Through methods similar to model targeting, Gp2 ligand discovery was performed using soluble biotinylated EGFR ectodomain as the target. After the second round of affinity maturation, strong binding was evident by flow cytometry with 50 nM soluble EGFR ( Figure 5A ). Deep sequencing indicated that GaEGFR 2.2.3 was the dominant clone in the library, and revealed several other families of sequences that were enriched during evolution. Purified Gp2-EGFR 2.2.3 binds to intact membrane-bound EGFR with an affinity of 18 ± 8 nM as measured by labeling A431 epidermoid carcinoma cells ( Figure 5B ) that highly overexpress EGFR on their surface (Hackel et al., 2012; Spangler et al., 2010) . Gp2-EGFR 2.2.3 exhibits secondary structure consistent with the wild-type Gp2 domain ( Figure 4C ) and is thermally stable (T m = 71 C ± 2 C, Figure 5C). Fluorescence microscopy was used to evaluate binding specificity. GaEGFR 2.2.3 , but not wild-type Gp2, effectively labels the cell surface of EGFR high A431 epidermoid carcinoma cells but not EGFR low MCF7 mammary carcinoma cells ( Figure 5D ). Moreover, binding of biotinylated GaEGFR 2.2.3 was blockable by excess unlabeled Gp2 ( Figure 5E ). Gp2 biotinylation was straightforward (with N-hydroxy succinimide biotin) due to the lone lysine residue at the N terminus. Figure 5F ).
Deep Sequencing of Naive and Binding Populations
Deep sequencing was performed on the original library and the first enriched population in each target campaign that displayed significant selective binding represented by a 10:1 ratio of cells on target beads to control beads. Multiple binding sequence families were identified for each target (4,209 unique sequences in 153 families identified by 85% sequence identity). Site-wise changes in amino acid frequencies, relative to the original library, for heavily diversified loops ( Figure 6A ) and framework sites subject to error-prone PCR ( Figure 6B ) reveal site-specific amino acid preferences. In addition, loop length frequency shows a slight change from the initial library to the evolved binders ( Figure 6C ).
DISCUSSION
We sought to identify a protein scaffold with a unique combination of small size and robust evolvability of specific, high-affinity binding while retaining stability, and sought to evaluate the ability to identify such a scaffold via systematic analysis of protein topology and an estimation of mutational tolerance. Gp2 provides very small size (5 kDa, 45 amino acids) and has been efficiently evolved, to four different targets, to picomolar to nanomolar affinities with good specificity including strong discrimination between related IgGs. Evolved molecules exhibit good thermal and chemical stability (T m = 65 C-80 C with reversible unfolding and tolerance to reverse-phase chromatography) and are functional in cellular assays. Gp2 succeeded with the combination of an effective topology, diversification design (tolerant loops of sufficient size, antibody-inspired amino acid bias, and shape diversity via loop length variation), and evolution method. The particular topology of an a helix opposite a three-strand b sheet underpinning two diversified loops is a new structure for a generalized binding scaffold. Of course, loops have been successful with numerous other topologies including-as examples rather than an all-inclusive list-antibodies, fibronectin domains, and GFP (Pavoor et al., 2009 ). Yet not all loop-presenting frameworks are equally efficacious, as evidenced by the varying performance of different scaffolds (Binz et al., 2005) . Of note here, the second candidate in our theoretical scaffold evaluation, an SH3 domain from CD2 associated protein (Roldan et al., 2011) , has substantially different framework topology and loop orientation (Figure 1 ). This SH3 domain is a homolog (rootmean-square deviation = 1.4 Å and TM score = 0.79, where >0.5 indicates similar fold; Zhang and Skolnick, 2005) of the Fynomer scaffold, which has been evolved for low-nanomolar affinity to five targets (Table S1 ) Panni et al., 2002) . While the scaffold evaluation algorithm provides a framework for comparison, comparative experimental evaluation of numerous scaffolds is beyond the scope of the current study. Importantly, the demonstrated efficacy of Gp2 provides evidence of an improved ability to merge design goals in evolutionary capacity, affinity, and stability if the topology is properly selected.
Regarding evolutionary library design, while the diversified loops provided sufficient diversity for high-affinity binding, adjacent framework mutations in several clones were noted (Table 1) . Deep sequencing suggests that added diversity at the N-terminal edge of the second loop could be beneficial, as E30, W31, and Q32 exhibited higher than average variance in binders relative to the naive library (p < 0.001), presumably resulting from error-prone PCR during evolution ( Figure 6B ). In addition, K1 also exhibits an increased mutation rate (p = 0.006), perhaps to account for change in exposure or structure due to the removal of the N-terminal tail. Conversely, lower than average mutation rates of sites F2, A4, P16, A25, Y33, and V40 (p < 0.001) suggest an evolutionary benefit to conservation at those sites. Notably, Y33 and V40 directly flank the diversified region of the second loop and are relatively buried in the protein core (19% and 21% solvent accessibility, respectively), suggesting a loopanchoring benefit. Overall, mutation tolerance correlated with solvent accessibility (p = 0.001, Figure S1 ). Antibody-inspired amino acid distribution was effective as it was closely maintained in binding sequences ( Figure 6A ), although evolutionary efficiency would benefit from slightly increased glycine, especially at select sites: amino acids 9-11 in the middle of the first loop and 34-35 at the start of the second loop. Meanwhile, evolutionary preference was evident for hydrophilic residues at sites 10 and 36 and hydrophobic residues at sites 12, 37, and 38. Loop length diversity was effectively utilized in binding sequences with a slight trend toward a longer first loop (18% decrease of wild-type 6-amino-acid length and 33% increase of 8-amino-acid loop; p < 0.001) and a second loop of wildtype length (12% increase; p < 0.001) ( Figure 6C ). Collectively, the diversification design was effective yet represents an avenue for improvement. While the Gp2 scaffold was robust in efficiently identifying effective binding molecules for each of the four disparate targets, one possible limitation is the modest number of lead molecules for each target. As scaffold size is reduced, the need to simultaneously optimize inter-and intramolecular interactions is heightened, and the solution space is diminished. While all evolved clones exhibited appropriate secondary structure, good thermal stability, and effective binding, the frequency of mutational tolerance of the naive library could be different. In fact, evolved proteins were readily produced in E. coli, albeit at moderate yields, and eight randomly selected initial library mutants were unable to be recovered in detectable amounts (data not shown), suggesting lack of solubility or stability in some naive mutants. Refining the combinatorial library using site-wise optimization of diversity based on the aforementioned data could improve the breadth of solutions. C to 98 C at 1 C per minute.
(C) Biotinylated IgG (2 nM goat or 4 nM rabbit as appropriate) was incubated with the indicated concentration of purified Gp2 and used to label yeast displaying the corresponding Gp2 clone. IgG binding was measured by streptavidin-fluorophore via flow cytometry.
(D) Purified GaGIgG2.2.1 was subjected to various treatments prior to use in the competitive binding assay (as in C). Unblocked is a control without Gp2 competition. Pre-HPLC uses competition by GaGIgG2.2.1 that was purified on a metal affinity column. Post-HPLC uses competition by GaGIgG2.2.1 purified by metal affinity chromatography and reverse-phase high-performance liquid chromatography and lyophilization. Post-heat uses competition by GaGIgG2.2.1 purified as in Post-HPLC along with heating to 98 C and cooling back to 22 C. Error bars are ±SD on n = 2 samples. See Figure S2 for GaLys A0.3.3 .
Effective lead ligands, such as GaEGFR 2.2.3 , which binds cellular EGFR with 18 ± 8 nM affinity and has high thermal stability (71 C), were identified. GaEGFR 2.2.3 was effective in cellular labeling for immunofluorescence, flow cytometry, and binding inhibition. Notably, GaEGFR 2.2.3 contains a single lysine at the N terminus, distal to the proposed binding paratope, for conjugation of imaging moieties or molecules of therapeutic interest. The conjugation of biotin to the molecule without strong inhibition of binding suggests that other molecules can similarly be conjugated. Similar small proteins have shown advantages over antibodies in molecular imaging of solid tumors (Natarajan et al., 2013; Orlova et al., 2009) , for which enhanced transport and clearance afforded by small size are particularly valuable, and have exhibited clinical potential (Baum et al., 2010) . It should be noted that, as with any synthetically engineered protein with non-human sequence components, immunogenicity of evolved molecules will need to be evaluated. Overall, Gp2 molecules represent a promising alternative with a unique blend of small size and robust evolution of stable, high-affinity binders.
SIGNIFICANCE
A systematic evaluation of the PDB based on size, protein secondary structure, paratope structure, and resilience to mutation led to further investigation of the small Gp2 domain. The ability to discover and evolve novel binding function on mutated Gp2 molecules is generalizable, with four targets currently tested. The small size, retention of thermal stability, and ease of evolving high-affinity binding provide a unique and powerful combination in an alternative scaffold. The Gp2 molecules reported here that bind strongly and specifically to rabbit IgG, goat IgG, lysozyme, and EGFR have immediate use in biotechnology or, in the case of GaEGFR 2.2.3 , as a potential clinical imaging agent, due to their single distal lysine available for conjugation of small molecules or other moieties. Moreover, deep sequencing of the binding populations provided insights on Gp2 evolution including mutational tolerance at nonloop positions and amino acid preference at individual loop positions. Overall, the initial successes of Gp2 combined with knowledge gained from sequence analysis suggest a promising scaffold that can be used to discover small, stable binders to many targets while providing an opportunity for ongoing study of evolutionary optimization of interand intramolecular interactions in a small scaffold.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in Supplemental Experimental Procedures.
PDB Analysis
All single domains within the PDB (accessed November 2011) were filtered to identify those with a size of 40-65 amino acids and at least 30% b sheet. Note that several proteins outside of these bounds were nevertheless returned by (B) Relative change in amino acid frequency by framework position from the naive library to combined mature populations. Certain mutations are more common than others due to error-prone PCR limitations. Positions where wild-type was conserved (#) or mutated (*) significantly more often (p < 0.001 for 3% deviation, n R 421) than the mean mutation rate are denoted. (C) Frequency of Gp2 loop length in amino acids. The naive library was designed with equal loop length frequencies, but DNA bias during construction lead to overrepresentation of shorter loops. Mature combines high throughput sequencing from the four binding populations. All have p < 0.001. Error bars are ±SD for n = 4.9 3 10 4 for naive and n R 477 for mature (number of damped sequences). See also Figure S1 . the website's filter. PyMol (Schrö dinger) was used to visualize the structures of the 259 remaining proteins, and those that contained two or more adjacent solvent-exposed loops whose surfaces formed one continuous face and had no disulfide bonds were further considered. The solvent-accessible surface area of the loop residues was calculated, using a 1.4-Å sphere, after mutating residues to serines in PyMol (Fraczkiewicz and Braun, 1998) . For the top 14 proteins, the destabilization upon random mutation of the loop residues was calculated using Eris (Yin et al., 2007) . Amino acid sequences were randomly generated using equal probability of each amino acid within the loops noted in Figure 1 . Random mutants were analyzed until the mean destabilization converged within 0.25 kcal/mol for at least ten consecutive mutants (minimum 35 mutants in total). This resulted in a maximum of 84 mutants with a median of 42 mutants.
Library Construction A genetic library was constructed based on a truncated form of T7 phage gene 2 protein, the top scoring protein, in which the sequence encoding for two loops was randomized using degenerate oligonucleotides encoding for an amino acid distribution mimicking antibody CDRs . At diversified positions ( Figure 1 ) the mixtures of nucleotides were 15% A and C, 25% G, and 45% T in the first position; 45% A, 15% C, 25% G, and 15% T in the second position; and 45% C, 10% G, and 45% T in the third position. The DNA was transformed into yeast surface display system strain EBY100 via homologous recombination with a pCT vector (Chao et al., 2006) . The total number of transformants was determined through serial dilution on SD-CAA plates (0.07 M sodium citrate [pH 5.3], 6.7 g/l yeast nitrogen base, 5 g/l casamino acids, and 20 g/l glucose). Flow cytometry was used to determine the amount of full-length Gp2 displayed, through labeling of the N-terminal HA epitope and C-terminal c-MYC epitope, and supported with DNA sequence verification. The design of the focused lysozyme library is described in Supplemental Experimental Procedures.
Binder Selection and Affinity Maturation
Yeasts displaying the Gp2 library were exposed to control magnetic beads (first avidin-coated beads, then beads with immobilized non-target protein) to remove any non-specific binding interactions. Yeasts were then exposed to magnetic beads with immobilized biotinylated target protein (goat IgG, rabbit IgG, lysozyme, or EGFR ectodomain) and bound yeasts were selected. Magnetic sorts on the initial library were performed at 4 C and only one wash. Non-naive populations were sorted more stringently, at room temperature and with three washes. Flow cytometry selections, with biotinylated target protein and Alexa Fluor 647-conjugated streptavidin, were used to isolate full-length (c-MYC positive) Gp2 domain mutants that bind selectively and with high affinity toward the target proteins. Loopfocused and total gene error-prone PCR, using nucleotide analogs, and genetic loop shuffling between binding sequences were used to evolve improved function (Hackel et al., 2008) .
Illumina MiSeq Analysis
Illumina MiSeq paired-end sequencing was conducted to obtain 4.9 3 10 4 reads from the naive library and a total of 6.4 3 10 5 (coefficient of variation = 24%) reads from binding populations. Loop 1 was analyzed independently from loop 2. Mature loop-1 sequences were grouped into 95 families (>60% sequence similarity) with 249 unique sequences, and after damping (quad rooted) the adjusted sequence count was n R 173 at each position. Mature loop-2 sequences were grouped into 96 families with 198 unique sequences, and after damping the adjusted sequence count was n R 96 at each position.
Sequences from the naive library population were grouped into 4.9 3 10 4 families with 4.9 3 10 4 unique sequences, and after damping the adjusted sequence count was R1.1 3 10 4 (due to fewer sequences at extended loop positions). Mature framework analysis grouped the sequences into 153 families (>85% sequence similarity) with 4,209 unique sequences, and after damping the adjusted sequence count was n R 421 at each position. p values were calculated using a Welch t test while assuming a normal distribution and using the number of damped sequences at each position as the sample size.
Affinity and Biophysical Properties
Binding affinities of evolved Gp2 molecules were determined by titrating target and evaluating binding using yeast surface display and flow cytometry (Chao et al., 2006) . For GaLys A0.3.3 Alexa Fluor 488-conjugated streptavidin was mixed equimolarly with singly biotinylated lysozyme at 2 mM prior to titration and yeast labeling. Gp2 domains were produced in E. coli, using strain JE1(DE3) for wildtype or BL21(DE3) for other Gp2 domains, purified by metal affinity chromatography and reverse-phase HPLC, and verified by mass spectrometry. Purified Gp2 was suspended at 0.2-0.9 mg/ml in PBS (8.0 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na 2 HPO 4 , 0.24 g/l KH 2 PO 4 [pH 7.2]) or 10 mM sodium acetate (pH 5.5), and secondary structure and thermal stability were evaluated by wavelength (200-260 nm) and temperature scans (25-98 C at 218 nm) via circular dichroism spectroscopy. Binding affinity was further measured by equilibrium competition titration with purified Gp2, target protein, and Gp2 displayed on the yeast surface using flow cytometry (Lipovsek et al., 2007) . For cellular EGFR affinity, A431 epidermoid carcinoma was cultured in DMEM with 10% fetal bovine serum at 37 C in humidified air with 5% CO 2 . Cells to be used in flow cytometry were detached using trypsin for a shorter time (3-5 min) than recommended. Table S1 , related to Figure 1 . Brief summary of scaffolds reported in literature that have been used to evolve novel binding activity. For a recent, in-depth review see (Škrlec et al., 2015) . (Angelini et al., 2012; Baeriswyl et al., 2012; Heinis et al., 2009) b (Getz et al., 2011; Kimura et al., 2011; Silverman et al., 2009; Souriau et al., 2005; Stricher et al., 2008; Zoller et al., 2012) c (Alm et al., 2010; Nilvebrant et al., 2011 Nilvebrant et al., , 2013 d (Eklund et al., 2002; Friedman et al., 2008; Grimm et al., 2011; Grönwall et al., 2007 Grönwall et al., , 2008 Huang et al., 2008; Koide et al., 1998; Kronqvist et al., 2011; Li et al., 2010; Lindborg et al., 2011; Löfdahl and Nygren, 2010; Nord et al., 2001; Olson et al., 2008; Rönnmark et al., 2002; Sandström et al., 2003; Wikman et al., 2004 Wikman et al., , 2006 e (Gera et al., 2011 (Gera et al., , 2012 Hussain et al., 2013) f (Banner et al., 2013; Bertschinger et al., 2007; Schlatter et al., 2012; Silacci et al., 2014) g (Béhar et al., 2013; Correa et al., 2014; h (Desmet et al., 2014) I (Hoffmann et al., 2012) j (Getmanova et al., 2006; Gilbreth et al., 2008 Gilbreth et al., , 2011 Karatan et al., 2004; Koide et al., 2012; Lipovsek et al., 2007; Mann et al., 2013; Richards et al., 2003; Sullivan et al., 2013; Wojcik et al., 2010; Xu et al., 2002) k (Silverman et al., 2005) l (Arbabi Ghahroudi et al., 1997; Dumoulin et al., 2002; Gottlin et al., 2009; Harmsen et al., 2006) m (Steemson et al., 2014) n (Beste et al., 1999; Lamla and Erdmann, 2003; Mercader and Skerra, 2002; Schlehuber et al., 2000; Vogt and Skerra, 2004) o (Fogolari et al., 2002; Kummer et al., 2012; Parizek et al., 2012; Schilling et al., 2014; Theurillat et al., 2010; Winkler et al., 2009) 
Supplemental Experimental Procedures
Library Construction A genetic library was constructed based on a truncated form of T7 phage gene 2 protein, the top scoring protein, in which the sequence encoding for two loops was randomized using degenerate oligonucleotides encoding for an amino acid distribution mimicking antibody CDRs . Naïve library design and construction was carried out as described previously . Degenerate nucleotides (Table below) , at diversified positions (sites 7-12 and 34-39, Figure 1 ), had 15% A and C, 25% G, and 45% T in the first position; 45% A, 15% C, 25% G, and 15% T in the second position; and 45 % C, 10% G, and 45% T in the third position. This mixture of nucleotides resulted in a theoretical amino acid composition of 17% Y, 13% S, 11%
D, 9% N, 6% A and H, 5% C and T, 4% G and P, 3% F, R, V, and Z, 2% L, I, E and K, 1% Q and W, and <1% M. The design also included three loop lengths in each loop: six (wild-type length), seven, or eight amino acids. Overlap extension reactions of eight oligonucleotides were carried out separately to create full-length Gp2 genes and avoid shorter loop length bias. Gene reactions were combined and transformed into EBY100 yeast using homologous recombination with linearized yeast surface display pCT vector (Chao et al., 2006) .
Degenerate oligonucleotides were used to create a diversified library heavily based on the parental lysozyme-binding clone found in high throughput sequencing. The amino acid composition at each residue was determined by weighing composition in previous binding sequences and natural homolog sequences, computational stability, and potential for complementarity. Previous binding sequences were counted as one family if they differed by two or fewer amino acids in the loop region, and the frequency of each family member was square rooted to avoid over counting dominant members. Running the NCBI BLAST online tool of the full length Gp2 gene sequence returned 32 natural homologous genes. These were translated and aligned in Clustal W2, and the frequency of amino acids at each position was counted.
Computational stability of the each loop site was calculated using the FoldX force field (Schymkowitz et al., 2005) . Four Gp2 structures from the PDB (2WNM, 2LMC, 4LK0, and 4LLG) had their loop regions randomized and then relaxed. For each random loop region, each loop position was mutated, independently, to the 19 other amino acids and the change in stability was calculated. The number of random loop sequences evaluated depended on how long each amino acid at each site took to converge to an average stability (between 40-50 depending on the structure). Stability was converted to a frequency by normalizing between 0 and 1 using S = exp(-ΔΔG/kT), setting kT = 1, and dividing by the sum at that position. Complementarity was based on the CDRs of antibodies; the frequencies were set equal to the initial diversity of the CDR-like diversification scheme. Frequency in previous binders was weighted heavily to ensure that the parental amino acid was present in the design. Natural sequences, complementarity, and stability were chosen to have a ratio of 1:2:16, respectively, based on the relative confidence and impact of each category. The final weights were 48%, 2.5%, 5%, and 40% for previous binders, natural homologs, complementarity, and stability, respectively. Possible amino acid combinations arising from degenerate codons were scored at each position. The design ( Table   S2 ) that remained below approximately 6 x 10 6 members with the highest product of position scores was chosen, using solvent accessible surface to break ties (giving more diversity for a more exposed position). 
Binder Selection and Affinity Maturation
Selection and maturation of yeast was performed largely following a previously outlined protocol . Briefly, yeast were grown to logarithmic phase in SD-CAA at 30 °C, pelleted and resuspended to 1-3 x 10 7 cells/mL in SG-CAA (0.1M sodium phosphate, mutagenized by error-prone PCR (Zaccolo et al., 1996) , using nucleotide analogs 2'-Deoxy-Pnucleoside-5'-Triphosphate and 8-Oxo-2'-deoxyguanosine-5'-Triphosphate (Trilink Biotechnologies, San Diego, CA), of the full gene or the diversified loops (both done in parallel (Hackel et al., 2008) ), and retransformed into yeast (Supplementary Table 2 ). Mutagenized populations underwent two rounds of magnetic sorting (both using three washes at 22 °C) and one flow cytometry sort. When dilution plating of the individual magnetic bead sorts indicated 5-10 fold more yeast collected during positive selection than yeast bound to the negative control protein conjugated beads, only one magnetic bead round (three washes at 22 °C) and one flow cytometry round were done for each mutagenized population.
To isolate the strongest affinity ligands, FACS was used as above. However, the collection gate was drawn so that only cells whose binding/display signal was in the top 1% were collected.
These cells were grown to saturation in SD-CAA medium and zymoprepped (Zymo Research Corp., Irvine, CA) to isolate plasmid DNA. Single plasmids were obtained by transforming 1 -5 µL of DNA into E. coli DH5α. Single colonies were grown in LB medium (tryptone (10 g/L), yeast extract (5 g/L), and sodium chloride (10 g/L)) containing ampicillin (100 mg/L) and miniprepped (Epoch Biolabs, Inc., Sugar Land, TX). Purified DNA was sent for sequencing to
Eurofins Genomics (Huntsville, AL).
The designed library based on the dominant clones from the Gp2-lysozyme Illumina sequencing was transformed into yeast and sorted with one normal bead sort round followed by FACS two times to isolate the strongest binders, as above.
Gp2 Production
The Gp2 Soluble affinity of select Gp2 proteins was determined using equilibrium competition titration, as described previously (Lipovsek et al., 2007) . Briefly, the soluble Gp2 clone was allowed sufficient time to reach 90% equilibrium with biotin-conjugated target over a range of Gp2
concentrations. Yeast cells displaying the same Gp2 clone and yeast cells harboring no plasmid (to aid in pelleting) were added to the solution, and allowed to equilibrate for six days. Cells were washed, labeled for target binding and analyzed with flow cytometry, as above.
A431 epidermoid carcinoma were kindly provided by Dr. Daniel Vallera (University of Minnesota). MDA-MB-231 mammary carcinoma were kindly provided by Dr. Jayanth Panyam (University of Minnesota). DU145 prostate carcinoma were kindly provided by Dr. Efrosini Kokkoli (University of Minnesota). MCF7 mammary carcinoma were kindly provided by Dr.
Deepali Sachdev (University of Minnesota). A431, MDA-MB-231, and MCF7 were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum at 37 ºC in humidified air with 5% CO 2 . DU145 was cultured in Minimum Essential Media with 10% fetal bovine serum at 37 ºC in humidified air with 5% CO 2 . 
Gp2
Illumina Analysis Preparation
To isolate the plasmid DNA from protein-displaying yeast, Zymoprep Yeast Plasmid Miniprep II was used. DNA samples from four separate magnetic bead sorted populations as well as the naïve library were divided into separate groups based on target binding campaign and naïve library. In total, five pools of DNA were isolated and separately analyzed. Following plasmid DNA extraction, two rounds of PCR were completed to assemble the Gp2 gene fragment with Illumina primers, index tags, multiplexing bar codes, and TruSeq universal adapter. For all PCR conducted during amplicon library preparation, KAPA HiFi polymerase was used as it has been shown to reduce clonal amplification bias due to GC content (van Dijk et al., 2014) as well as fragment length bias (Dabney and Meyer, 2012) . Compatible multiplexing and adapter primers were designed according to TruSeq sample preparation guidelines. To increase library sequence diversity, ~25% PhiX control library was spiked in which is common practice for amplicons with large regions of conservation. Samples were submitted to the University of Minnesota Genomics
Center.
Full length, in frame Gp2 sequences were isolated from Pandaseq assembled (Masella et al., 2012) Illumina files. For the binding populations, loop sequences that had fewer than 28 occurrences were ignored to account for background from carryover during bead sorting. At each position within a family, amino acid counts were summed and then damped (quad rooted) and frequency was calculated from the sum across families. The amount of dampening was chosen to balance importance of dominant sequences, multiplied many fold during directed evolution, and rare sequences, containing important information about tolerated mutations. For framework analysis the family threshold was set to 85% and damped (quad root), these values were selected for the same reasons as above but the family threshold is different due to the change in amino acid length of the analyzed section.
Fluorescence Microscopy
A431 and MCF7 cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum at 37 ºC in humidified air with 5% CO 2 in a 12 well plate. At ~80% confluency media was removed and cells were washed three times by adding 1 mL PBSA and aspirating. 1 mL of 100 nM of Gp2 was added to the wells and incubated for 15 min at 4 °C. Cells were washed three times with PBSA. 0.3 mL of fluorescein conjugated rabbit anti-His 6 antibody was added to each well and incubated for 5-10 min at 4 °C. Cells were washed three times with PBSA and viewed on an Evos Fl microscope (Advanced Microscopy Group, Mill Creek, WA).
Circular Dichroism
Purified Gp2 was lyophilized and resuspended in PBS or 10 mM sodium acetate pH 5.5 (for GαLys A0.3.3 and GαEGFR 2.2.3 due to low solubility in PBS) to a concentration of 0.2-0.9 mg mL -1 . Ellipticity was measured from 260 to 200 nm on a Jasco J-815 (Jasco, Inc., Easton, MD) spectrophotometer in a quartz cuvette with 1 mm path length. Thermal denaturation was carried out by measuring the ellipticity at 218 nm from 25 to 98 °C and T m was calculated from a standard two-state unfolding curve.
